The invention provide novel pyrimidine derivatives and analogs having inhibitory activities towards certain tyrosine kinases, e.g., Bruton's tyrosine kinase (Btk) and/or Focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), pharmaceutical compositions thereof, and methods of treatment, reduction or prevention of certain diseases or conditions mediated by such by tyrosine kinases, e.g., cancers, tumors, fibrosis, inflammatory diseases, autoimmune diseases, diabetes, or immunologically mediated diseases.
该发明提供了具有抑制活性的新型
嘧啶衍
生物和类似物,例如对某些
酪氨酸激酶(例如Bruton's
酪氨酸激酶(Btk)和/或Focal粘附激酶(FAK)以及细胞外信号调节激酶(ERK))具有抑制活性的
嘧啶衍
生物和类似物,以及药物组合物,以及治疗、减少或预防由这些
酪氨酸激酶介导的某些疾病或病况的方法,例如癌症、肿瘤、纤维化、炎症性疾病、自身免疫疾病、糖尿病或免疫介导性疾病。